Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic,Diabetes Technology & Therapeutics

当前位置： X-MOL 学术 › Diabetes Technol. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic
Diabetes Technology & Therapeutics ( IF 5.7 ) Pub Date : 2021-09-01 , DOI: 10.1089/dia.2021.0080
Joyce M Lee ₁ , Emily Carlson ₂ , Anastasia Albanese-O'Neill ₃ , Carla Demeterco-Berggren ₄ , Sarah D Corathers ₅ , Francesco Vendrame ₆ , Ruth S Weinstock ₇ , Priya Prahalad ₈ , Guy Todd Alonso ₉ , Manmohan Kamboj ₁₀ , Daniel J DeSalvo ₁₁ , Faisal S Malik ₁₂ , Roberto Izquierdo ₇ , Osagie Ebekozien _{2,

13}

Affiliation

C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA.
T1D Exchange, Boston, Massachusetts, USA.
University of Florida, Gainesville, Florida, USA.
Rady Children's Hospital/University of California, San Diego, California, USA.
Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
University of Miami Miller School of Medicine, Miami, Florida, USA.
SUNY Upstate Medical University, Syracuse, New York, USA.
Lucile Packard Children's Hospital/Stanford University, Palo Alto, California, USA.
Barbara Davis Center, University of Colorado, Aurora, Colorado, USA.
Nationwide Children's Hospital, Columbus, Ohio, USA.
Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
University of Washington, Seattle, Washington, USA.
Bower School of Population Health, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Background: We describe the utilization of telemedicine visits (video or telephone) across the type 1 diabetes (T1D) Exchange Quality Improvement Collaborative (T1DX-QI) during the COVID-19 pandemic. Metrics, site-level survey results, and examples of interventions conducted to support telemedicine in T1D are shown.

中文翻译：

在 COVID-19 大流行期间采用远程医疗进行 1 型糖尿病护理

背景：我们描述了在 COVID-19 大流行期间 1 型糖尿病 (T1D) 交流质量改进协作 (T1DX-QI) 远程医疗就诊（视频或电话）的利用情况。显示了为支持 T1D 远程医疗而进行的指标、站点级调查结果和干预示例。

更新日期：2021-09-03

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11